Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.

  • Read more about Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.

Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.

  • Read more about Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.

Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).

  • Read more about Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).

Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia.

  • Read more about Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia.

Central venous catheter complications in sickle cell disease.

  • Read more about Central venous catheter complications in sickle cell disease.

Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia.

  • Read more about Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia.

The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group.

  • Read more about The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group.

Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease.

  • Read more about Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease.

Deferoxamine treatment during pregnancy: is it harmful?

  • Read more about Deferoxamine treatment during pregnancy: is it harmful?

Surgery in patients with hemoglobin SC disease. Preoperative Transfusion in Sickle Cell Disease Study Group.

  • Read more about Surgery in patients with hemoglobin SC disease. Preoperative Transfusion in Sickle Cell Disease Study Group.

Pagination

  • Previous page ‹‹
  • Page 5
  • Next page ››
Subscribe to American journal of hematology

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List